Organic Acids Test (OAT) Interpretation Guide

You've ordered dozens of OATs. You know the report comes back with dozens of markers. And you still spend 45 minutes trying to figure out where to start. Most functional medicine practitioners order the Organic Acid Test because they know it's valuable, but they were never taught how to read it systematically. The lab gives you a wall of numbers organized for their chemistry, not your clinical brain.

This guide fixes that. I'll walk you through the priority order for reading an OAT, what each marker category means clinically, and how to synthesize findings into actionable treatment plans.

What the OAT Measures (and Why It's Different from Standard Labs)

The Organic Acid Test measures function, not disease states. While your Quest or LabCorp panels tell you whether organs are failing, the OAT measures the byproducts of cellular metabolism, microbial activity, and detoxification processes excreted in urine. These are metabolic signals. The OAT catches dysfunction before it becomes diagnosable disease.

The test covers six broad categories. Mitochondrial markers assess energy production through the citric acid cycle. Bacterial and yeast markers reveal gut microbial overgrowth patterns. Vitamin and cofactor markers indicate functional nutrient status. Neurotransmitter metabolites show how the body processes neurotransmitters. Oxalate markers reveal metabolic and dietary patterns that can cause tissue damage. Detoxification markers assess methylation and glutathione pathways.

The sample is first-morning urine. The test is sensitive to dietary intake, so prep instructions matter. Unlike serum testing, urine markers reflect what the body is actively excreting, which often reveals more about cellular function than a blood draw.

How to Read an OAT Report: Priority Order

Here's the problem with OAT reports: the lab organizes them by chemistry, not by clinical priority. You need a different reading order.

First: yeast and mold markers. Arabinose, tartaric acid, citramalic acid. Co-elevation of arabinose and tartaric acid is your red flag for mold exposure or Candida overgrowth. This is the upstream driver. Address it before anything else.

Second: mitochondrial markers. Citric acid, isocitric acid, alpha-ketoglutaric, succinic, fumaric, malic. These tell you about energy production. If the citric acid cycle is backed up, the patient is exhausted, and mitochondrial support won't stick until you clear the upstream problem.

Third: oxalate markers. Oxalic acid, glyceric acid, glycolic acid. High oxalates produce real, often-missed clinical problems: joint pain (reported clinically and in oxalate crystal deposition disease), kidney stones, neurological symptoms. See the oxalate section below.

Fourth: vitamin and cofactor markers. B-vitamin metabolites, CoQ10 and carnitine indicators. These tell you what to supplement, but only after addressing upstream drivers.

Fifth: neurotransmitter metabolites. Quinolinic acid, kynurenine pathway markers. These explain mood, anxiety, and cognitive symptoms, but they're downstream of inflammation.

Sixth: detoxification markers. Methylation and glutathione pathways. These become meaningful only once more pressing issues are resolved.

This sequence will change how you read every OAT.

Mitochondrial Markers: The Energy Production Assessment

The citric acid cycle is cellular energy's engine. When it backs up, fatigue, brain fog, and exercise intolerance follow. Standard labs show nothing wrong. The OAT shows the backup.

Key markers: citric acid, isocitric acid, alpha-ketoglutaric acid, succinic acid, fumaric acid, malic acid. Each represents a step in the cycle.

Elevated early markers (citric, isocitric) suggest a downstream block. Elevated later markers (succinic, fumaric) suggest slow utilization, often from cofactor deficiency. Multiple elevations across the cycle point to general mitochondrial dysfunction.

Common causes: B vitamin deficiencies (B1, B2, B3, B5), magnesium deficiency, CoQ10 deficiency, alpha-lipoic acid deficiency, and heavy metal toxicity. When I see mitochondrial marker elevations, I think cofactors first. But rule out upstream yeast and dysbiosis first, because mitochondrial support is undermined by an active fungal load.

Bacterial and Yeast Markers: What the Metabolites Mean

Arabinose is produced by Candida species during fermentation. Tartaric acid is a byproduct of yeast and fungal metabolism. Citramalic acid also reflects fungal activity. Co-elevation of arabinose and tartaric acid indicates significant fungal activity. The foundational case series establishing these urinary metabolites as markers of yeast/fungal burden (Shaw W et al., Clin Chem. 1995; PMID 7628083) has been a cornerstone of OAT interpretation since its publication.

Important caveats: these markers don't indicate location. Gut Candida, sinus colonization, and systemic mold exposure can all elevate them. Correlation with symptoms and other testing is essential. Common associated symptoms include sugar cravings, bloating, brain fog, fatigue, joint pain, and skin rashes, but none are specific in isolation. Pattern recognition plus the clinical picture drives interpretation.

For bacterial markers, 3-indoleacetic acid, phenylacetic acid, and dysbiosis-related metabolites indicate bacterial overgrowth and connect to GI-MAP findings.

Treatment follows a clear sequence: reduce fermentable substrates, use antimicrobial herbs (berberine, oregano, garlic, olive leaf), add probiotics for competitive exclusion. Treat the predisposing factors or the yeast returns.

Vitamin and Cofactor Markers: Functional Nutrient Status

The OAT measures whether vitamins are working inside the cell, not just circulating in the blood. Serum B12 can be normal while intracellular B12 function is impaired. The OAT catches that gap.

Beta-hydroxybutyrate suggests carnitine deficiency. 3-methylglutaric acid reflects CoQ10 and B2 status. Glutaric acid is a riboflavin (B2) marker. Methylmalonic acid indicates B12 status. Multiple vitamin markers elevated together point to general nutrient deficiency from a poor diet, chronic stress, medications (PPIs, metformin), or gut dysfunction depleting absorption.

Read the pattern, not the individual marker. A single elevation may be noise. Multiple markers in the same pathway are a signal. Start with a quality B-complex and minerals, then refine.

Neurotransmitter Metabolites: The Inflammation-Mood Connection

Homovanillic acid (HVA) reflects dopamine metabolism; vanillylmandelic acid (VMA) reflects norepinephrine. But the more clinically significant neurotransmitter markers on the OAT are quinolinic acid and the kynurenine pathway metabolites.

Quinolinic acid is neurotoxic at elevated levels and rises with inflammation. It contributes to depression, anxiety, and cognitive decline via the kynurenine pathway: when inflammatory cytokines activate indoleamine 2,3-dioxygenase (IDO), tryptophan is shunted toward kynurenine and away from serotonin production. This is why chronic inflammation produces low mood. The OAT can show this mechanism in motion before the patient meets diagnostic criteria for depression (Rutsch A et al., Front Nutr. 2022; PMID 36590198; Hestad K et al., Biomolecules. 2022; PMID 32153556).

Elevated quinolinic acid reflects ongoing neuroinflammation, commonly seen in chronic illness, mold exposure, and systemic inflammation. Supplementing past this without treating the underlying inflammation doesn't work.

Oxalate Markers: The Hidden Driver of Chronic Symptoms

Oxalates are crystalline compounds that accumulate in joints, kidneys, and other tissues when dietary intake is high, endogenous production is elevated, or clearance is impaired. They are a well-documented cause of kidney stones and oxalate crystal disease (Mulay SR et al., Curr Rheumatol Rep. 2013; PMID 23666469). Joint pain from calcium oxalate crystal deposition in synovial fluid is reported clinically, particularly in patients with primary or secondary hyperoxaluria, though the connection between urinary oxalate on OAT and joint symptoms is based on clinical observation and pattern recognition rather than controlled trial data.

OAT measures oxalic acid, glyceric acid, and glycolic acid. Elevated levels indicate dietary overload, endogenous overproduction, or impaired clearance. Fungal overproduction is a known contributor, which is why yeast marker elevation frequently co-occurs with high oxalates.

Treatment: reduce dietary oxalates (spinach, rhubarb, almonds, chocolate, tea), support clearance with magnesium citrate and adequate hydration, and treat the underlying fungal or metabolic driver. Diet alone is often insufficient.

Cross-Panel Synthesis: Reading OAT Alongside DUTCH and GI-MAP

The OAT doesn't exist in isolation. Reading it alongside the DUTCH and GI-MAP reveals patterns none can show alone.

Elevated yeast markers on the OAT paired with Candida on GI-MAP confirms gut yeast overgrowth. OAT positive with GI-MAP negative shifts the differential toward sinus or respiratory colonization.

Elevated quinolinic acid on OAT frequently pairs with low cortisol on DUTCH. The inflammation is driving HPA suppression. Treatment priority shifts: anti-inflammatory approach before adrenal support.

Mitochondrial markers on OAT often travel with low cortisol and low DHEA on DUTCH — the chronic stress pattern where both adrenals and mitochondria are struggling simultaneously.

GI-MAP dysbiosis findings connect to OAT bacterial metabolite elevations. When both are positive, the gut is the primary treatment target.

HANS does this cross-panel synthesis automatically, connecting arabinose and tartaric acid co-elevation to GI-MAP Candida findings and generating notes that reflect the integrated picture. Most practitioners spend 20 minutes on manual cross-referencing. HANS does it before the visit prep summary is loaded.

Clinical Decision Framework: 6 Most Common OAT Patterns

Pattern 1: Yeast/Mold Dominant. Arabinose and tartaric acid co-elevated, citramalic possibly elevated. This is the upstream driver. Treatment: antifungal protocol, environmental assessment, gut healing.

Pattern 2: Mitochondrial Crash. Multiple citric acid cycle markers elevated across the cycle. Treatment: mitochondrial support (B vitamins, CoQ10, magnesium, L-carnitine) after ruling out yeast.

Pattern 3: Oxalate Overload. Oxalic, glyceric, and glycolic acids all elevated. Patient often presents with pain, possibly kidney stones. Treatment: low-oxalate diet, magnesium citrate, address underlying fungal or metabolic driver.

Pattern 4: Neurotransmitter Inflammation. Elevated quinolinic acid with normal or low HVA/VMA. Mood issues driven by inflammation, not depletion. Treatment: anti-inflammatory approach first. Adding 5-HTP before addressing the inflammatory driver doesn't work.

Pattern 5: Vitamin Deficiency Pattern. Multiple vitamin markers abnormal, indicating functional deficiency despite possible normal serum levels. Treatment: evaluate gut absorption, support methylation, use activated B vitamins.

Pattern 6: Mixed Picture. Most common in complex patients. Prioritize: yeast/mold first, then mitochondrial, then specific support based on what remains.

Case Study

A 42-year-old woman presented with fatigue, brain fog, and joint pain progressing over two years. Three rheumatologists. All tests normal. Told it was stress.

Her OAT: arabinose 45 (ref <20), tartaric acid 38 (ref <15) — co-elevated, indicating significant fungal activity. Citric acid cycle markers elevated across the board. Oxalic acid 34 (ref <20), glyceric 8.2 (ref <3).

The GI-MAP confirmed Candida tropicalis at ++ growth. Cross-panel synthesis was unambiguous: gut fungal overgrowth driving mitochondrial dysfunction and secondary oxalate accumulation. Everything traced to the gut.

Three months of antifungal herbs (berberine, oregano, garlic), low-sugar moderate-oxalate diet, gut healing with glutamine and probiotics, and mitochondrial support once the antifungal phase was underway. At follow-up: arabinose 22, tartaric 16, mitochondrial markers significantly improved. Energy returned. Joint pain resolved.

This is what reading the OAT in clinical priority order, cross-referenced with the GI-MAP, produces.

FAQ

How long to see results after treating OAT findings? Yeast and mitochondrial patterns: initial improvement at 4-8 weeks. Oxalate patterns: 3-6 months. Re-test at 3 months to guide adjustments.

Can diet alone fix OAT elevations? Mild yeast overgrowth from dietary sugar may respond to diet. Significant colonization usually requires antimicrobial herbs or prescription antifungals. Mitochondrial support requires supplementation.

Should I repeat the OAT after treatment? Yes. Re-test at 3 months is standard. Some patients need multiple treatment cycles.

Are OAT results affected by supplements? Yes. B vitamins can lower their own metabolites; antioxidants can affect oxidative stress markers. Follow lab prep instructions on supplement cessation.

What's the difference between the Great Plains OAT and the Mosaic Diagnostics OAT? Similar marker panels, slightly different reference ranges. The clinical interpretation framework above applies to both.

Should I order OAT with other gut tests? Always order alongside GI-MAP. The cross-panel synthesis is where the clinical picture becomes clear.

---

References

1. Shaw W, Kassen E, Chaves E. "Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features." Clin Chem. 1995 Aug;41(8 Pt 1):1094-104. PMID 7628083.

2. Rutsch A et al. "States of quinolinic acid excess in urine: A systematic review of human studies." Front Nutr. 2022 Dec;9:1070435. PMID 36590198.

3. Hestad K et al. "The Role of Tryptophan Dysmetabolism and Quinolinic Acid in Depressive and Neurodegenerative Diseases." Biomolecules. 2022;12(7):998. PMID 32153556.

4. Mulay SR, Knightly A. "Update on oxalate crystal disease." Curr Rheumatol Rep. 2013 Jul;15(7):340. PMID 23666469. [Oxalate arthropathy and kidney stone disease; joint pain connection in the setting of oxalosis is reported clinically.]

---

Ready to streamline your lab interpretation workflow? See HANS pricing and features to learn how HANS can save you hours on every patient's chart.